Drug intelligence / Profile preview

BOX202-1

Development stage
Unknown
Lead developer
Bostal Pharma
Modality
Small Molecules
Administration
Subcutaneous
01

Overview

BOX202-1 is a once-monthly (1M) long-acting injectable (LAI) formulation of brexpiprazole, developed by Bostal Pharma (Bostal Drug Delivery) using its proprietary in-situ gel-forming depot technology (Geleepot®). Brexpiprazole is an atypical antipsychotic that acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. BOX202-1 is designed to improve treatment adherence and provide sustained symptom control in patients with schizophrenia and agitation associated with dementia due to Alzheimer's disease. It is currently in Phase 2/3 clinical development.

Other names
Brexpiprazole LAI 1MBrexpiprazole long-acting injectable (1-month formulation)Brexpiprazole once-monthly long-acting formulationepiliprazole gelepiprazole gel依匹哌唑凝胶
02

Targets

HTR2A (Serotonin receptor 5-HT2A)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))DRD2 (Dopamine D2 Receptor)

Beyond the preview

Go deeper on BOX202-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BOX202-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call